Get the Stockscreener App
2.23
211.69%
1.537
Marpai Inc stock is traded at $2.23, with a volume of 73,515.
It is up +211.69% in the last 24 hours and up +211.69% over the past month.
See More
Previous Close:
$0.693
Open:
$2.21
24h Volume:
73,515
Relative Volume:
12.89
Market Cap:
$N/A
Revenue:
$18.10M
Net Income/Loss:
$-16.56M
P/E Ratio:
-2.3324
EPS:
-0.9561
Net Cash Flow:
$-7.45M
1W Performance:
+211.69%
1M Performance:
+211.69%
6M Performance:
+61.19%
1Y Performance:
+3.84%
1-Day Range:
$2.16
$2.26
1-Week Range:
$2.16
$2.26
52-Week Range:
$0.2564
$2.26
Marpai Inc Stock (MRAI) Company Profile
Compare MRAI vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRAI
Marpai Inc
|
2.23 | 0 | 18.10M | -16.56M | -7.45M | -0.9561 |
UNH
Unitedhealth Group Inc
|
395.57 | 360.59B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
94.03 | 124.26B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
390.37 | 86.82B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
275.39 | 74.66B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
384.31 | 46.72B | 137.20B | 1.15B | 1.27B | 9.3439 |
Marpai Inc Stock (MRAI) Latest News
Marpai expands Claritev agreement for payment integrity - Investing.com
Marpai expands beyond network access—but what comes next? - Stock Titan
Marpai Expands Relationship With Claritev To Help Reduce Healthcare Costs For Employer Clients - TradingView
Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients - Business Wire
Marpai Q2 revenue down 10.5% to USD 4.2M - Medical Buyer
Marpai Q2 loss per share narrows to $(0.18) as revenue falls 10.5% - scanx.trade
Marpai Q2 revenue falls due to turnover and continued customer pruning - TradingView
Marpai Reports Second Quarter 2026 Financial Results - PR Newswire
Marpai, Inc. (MRAI) flags going-concern risk amid heavy debt and losses - Stock Titan
Marpai (MRAI) investor group discloses 10.1% stake and board observer rights - Stock Titan
Calvin Steven Mitchell Discloses Investment at Marpai, Inc. with 9.3% Stake - TradingView
Marpai, Inc. (MRAI) gains 9.3% shareholder as Mitchell and Benchmark file 13D - Stock Titan
Marpai, Inc. (MRAI) insider details warrants and 3M-share preferred conversion - Stock Titan
Marpai, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Marpai cuts costs, improves margins, and streng... - Pluang
Enterprise value to EBITDA forward of Marpai, Inc. – OTC:MRAI - TradingView
Marpai Raises $12.1 Million in Series A Preferred Private Placement Led by Mitchell Companies - TradingView
Marpai lands $12.1M private placement led by Mitchell Companies - Dealroom
Marpai raises $12 million in private placement By Investing.com - Investing.com Nigeria
Marpai Announces $12 Million Private Placement led by Mitchell Companies - PR Newswire
Price to sales forward of Marpai, Inc. – OTC:MRAI - TradingView
Marpai Highlights Major Debt Restructuring to Boost Flexibility - The Globe and Mail
Marpai Restructures AXA Maestro Purchase Payments; Defers 35% Proceeds Until $5M Raised - TradingView
Marpai Restructures Debt, Cuts Near-Term Debt Service by $26.4 Million - citybiz
Marpai Extends Debt Maturities to April 2028 and Dec. 2029 - Stock Titan
Marpai Inc. Announces Debt Restructuring Agreements with JGB Capital and AXA, Reducing Debt Service by $26.4 Million Through 2027 and Enhances Near term Liquidity - PR Newswire
Dallas Scrip Net Worth (2026) - GuruFocus
Marpai CFO Steve Johnson buys $682 in stock, granted award By Investing.com - Investing.com India
[Form 4] Marpai, Inc. Insider Trading Activity - Stock Titan
Marpai CFO Steve Johnson buys $682 in stock, granted award - Investing.com
Marpai (MRAI) director receives 175,000-share grant and forfeits 50,000 RSUs - Stock Titan
Marpai (MRAI) director reports 125,000-share RSU grant and 50,000 RSU forfeiture - Stock Titan
Marpai (MRAI) director reports 100K RSU grant and 484K shares - Stock Titan
Marpai (MRAI) director gets 100,000-share RSU grant, forfeits 50,000 - Stock Titan
Marpai (MRAI) director DiClaudio receives 125,000-share fully vested stock grant - Stock Titan
Marpai secures 192,000 new member lives, projects profitability - Investing.com
Marpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026 - PR Newswire
Marpai (MRAI) director Eitan Yaron adds 10,000 shares in open-market buy - Stock Titan
MARPAI reports net loss of USD 3.2M in Q1 2026 - Medical Buyer
Marpai reports Q1 2026 results with cloud migration nearing completion and targets profitability in H2 2026 - Pluang
Marpai reports Q1 loss, targets second-half profitability - Investing.com
Marpai reports Q1 loss, targets second-half profitability By Investing.com - Investing.com Nigeria
Marpai (MRAI) Q1 2026 shows losses, heavy debt and going concern risk - Stock Titan
BRIEF-Marpai Q1 Revenue USD 4.4 Million - TradingView
MARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS - PR Newswire
Marpai secures major new contracts, boosting path to profitability with integrated healthcare services. - Pluang
Marpai, Inc. Announces Significant New Business Wins across TPA and MarpaiRx; Solidifies Forecast for Profitability - The Norfolk Daily News
Marpai Extends Maturity of Insider Promissory Notes - TipRanks
Marpai (MRAI) pushes $660,000 CEO promissory notes out to Sept. 1, 2026 - Stock Titan
Marpai, Inc. (MRAI) - Minichart
Marpai (MRAI) director receives 100,000 RSUs tied to strategic deal - Stock Titan
Marpai Inc Stock (MRAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.48%
Cap:
|
Volume (24h):